One Stop Shop for All Your Market Research Reports

Global Multiple Sclerosis Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems. Scope of the Report: This report studies the Multiple Sclerosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Multiple Sclerosis market by product type and applications/end industries. Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development. The global Multiple Sclerosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Multiple Sclerosis. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers Abbvie Acorda Therapeutics Bayer HealthCare Biogen Genzyme (Sanofi) GlaxoSmithKline Merck Serono Novartis Pfizer Teva Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Injectable agents Oral agents Market Segment by Applications, can be divided into Hosptial Research
Table of Contents 1 Multiple Sclerosis Market Overview 1.1 Product Overview and Scope of Multiple Sclerosis 1.2 Classification of Multiple Sclerosis by Types 1.2.1 Global Multiple Sclerosis Revenue Comparison by Types (2017-2023) 1.2.2 Global Multiple Sclerosis Revenue Market Share by Types in 2017 1.2.3 Injectable agents 1.2.4 Oral agents 1.3
Inquiry Before Buying

Request Sample

Share This Report

Our Clients

Payment Mode
Single User US $ 3480
Multi User US $5220
Corporate User US $6960
About this Report
Report ID 306684
Category
  • Medical Devices
Published on 11-Jan
Number of Pages 128
Publisher Name Global Info Research
Editor Rating
★★★★★
★★★★★
(25)